APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biomedical CRO

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biomedical CRO Market Analysis and Forecast 2026-2032

Report ID 17407934021 January 2026199 pages

Choose your research edition.

Industry ResearchBiomedical CRO Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Biomedical CRO Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biomedical CRO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biomedical CRO Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Biomedical CRO Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Biomedical CRO market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biomedical CRO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biomedical CRO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biomedical CRO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biomedical CRO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biomedical CRO include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, ICON Plc, Pharmaron, Inotiv and ChemPartner, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biomedical CRO, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biomedical CRO, also provides the revenue of main regions and countries. Of the upcoming market potential for Biomedical CRO, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biomedical CRO revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biomedical CRO market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biomedical CRO revenue, projected growth trends, production technology, application and end-user industry.

Biomedical CRO Segment by Company

Charles River

Wuxi AppTec

Labcorp

Eurofins Scientific

PPD

ICON Plc

Pharmaron

Inotiv

ChemPartner

JOINN Lab

EVOTEC

Medicilon

Crown Bioscience

Champion Oncology

Biomedical CRO Segment by Type

Preclinical CRO

Clinical CRO

Biomedical CRO Segment by Application

Biological Industry

Medical Industry

Biomedical CRO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomedical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical CRO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biomedical CRO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biomedical CRO company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomedical CRO revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biomedical CRO Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Preclinical CRO Major Player Table 3. Clinical CRO Major Player Table 4. Global Biomedical CRO Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Biological Industry Major Player Table 6. Medical Industry Major Player Table 7. Biomedical CRO Industry Trends Table 8. Biomedical CRO Industry Drivers Table 9. Biomedical CRO Industry Opportunities and Challenges Table 10. Biomedical CRO Industry Restraints Table 11. Global Biomedical CRO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Biomedical CRO Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Biomedical CRO Market Share by Region (2021-2026) Table 14. Global Biomedical CRO Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Biomedical CRO Market Share by Region (2027-2032) Table 16. Global Biomedical CRO Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Biomedical CRO Revenue Market Share by Players (2021-2026) Table 18. Global Biomedical CRO Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Biomedical CRO Key Players Headquarters & Area Served Table 20. Global Biomedical CRO Players, Product Type & Application Table 21. Global Biomedical CRO Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Biomedical CRO by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Biomedical CRO Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Biomedical CRO Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Biomedical CRO Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Biomedical CRO Revenue Market Share by Type (2021-2026) Table 28. Global Biomedical CRO Revenue Market Share by Type (2027-2032) Table 29. Global Biomedical CRO Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Biomedical CRO Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Biomedical CRO Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Biomedical CRO Revenue Market Share by Application (2021-2026) Table 33. Global Biomedical CRO Revenue Market Share by Application (2027-2032) Table 34. Charles River Company Information Table 35. Charles River Business Overview Table 36. Charles River Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Charles River Biomedical CRO Product Portfolio Table 38. Charles River Recent Development Table 39. Wuxi AppTec Company Information Table 40. Wuxi AppTec Business Overview Table 41. Wuxi AppTec Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Wuxi AppTec Biomedical CRO Product Portfolio Table 43. Wuxi AppTec Recent Development Table 44. Labcorp Company Information Table 45. Labcorp Business Overview Table 46. Labcorp Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Labcorp Biomedical CRO Product Portfolio Table 48. Labcorp Recent Development Table 49. Eurofins Scientific Company Information Table 50. Eurofins Scientific Business Overview Table 51. Eurofins Scientific Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Eurofins Scientific Biomedical CRO Product Portfolio Table 53. Eurofins Scientific Recent Development Table 54. PPD Company Information Table 55. PPD Business Overview Table 56. PPD Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. PPD Biomedical CRO Product Portfolio Table 58. PPD Recent Development Table 59. ICON Plc Company Information Table 60. ICON Plc Business Overview Table 61. ICON Plc Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. ICON Plc Biomedical CRO Product Portfolio Table 63. ICON Plc Recent Development Table 64. Pharmaron Company Information Table 65. Pharmaron Business Overview Table 66. Pharmaron Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Pharmaron Biomedical CRO Product Portfolio Table 68. Pharmaron Recent Development Table 69. Inotiv Company Information Table 70. Inotiv Business Overview Table 71. Inotiv Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Inotiv Biomedical CRO Product Portfolio Table 73. Inotiv Recent Development Table 74. ChemPartner Company Information Table 75. ChemPartner Business Overview Table 76. ChemPartner Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. ChemPartner Biomedical CRO Product Portfolio Table 78. ChemPartner Recent Development Table 79. JOINN Lab Company Information Table 80. JOINN Lab Business Overview Table 81. JOINN Lab Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. JOINN Lab Biomedical CRO Product Portfolio Table 83. JOINN Lab Recent Development Table 84. EVOTEC Company Information Table 85. EVOTEC Business Overview Table 86. EVOTEC Biomedical CRO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. EVOTEC Biomedical CRO Product Portfolio Table 88. EVOTEC Recent Development Table 89. Medicilon Company Information Table 90. Medicilon Business Overview Table 91. Medicilon Biomedical CRO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Medicilon Biomedical CRO Product Portfolio Table 93. Medicilon Recent Development Table 94. Crown Bioscience Company Information Table 95. Crown Bioscience Business Overview Table 96. Crown Bioscience Biomedical CRO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Crown Bioscience Biomedical CRO Product Portfolio Table 98. Crown Bioscience Recent Development Table 99. Champion Oncology Company Information Table 100. Champion Oncology Business Overview Table 101. Champion Oncology Biomedical CRO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Champion Oncology Biomedical CRO Product Portfolio Table 103. Champion Oncology Recent Development Table 104. North America Biomedical CRO Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Biomedical CRO Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Biomedical CRO Revenue by Application (2021-2026) & (US$ Million) Table 107. North America Biomedical CRO Revenue by Application (2027-2032) & (US$ Million) Table 108. North America Biomedical CRO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America Biomedical CRO Revenue by Country (2021-2026) & (US$ Million) Table 110. North America Biomedical CRO Revenue by Country (US$ Million) & (2027-2032) Table 111. Europe Biomedical CRO Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe Biomedical CRO Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe Biomedical CRO Revenue by Application (2021-2026) & (US$ Million) Table 114. Europe Biomedical CRO Revenue by Application (2027-2032) & (US$ Million) Table 115. Europe Biomedical CRO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Europe Biomedical CRO Revenue by Country (2021-2026) & (US$ Million) Table 117. Europe Biomedical CRO Revenue by Country (US$ Million) & (2027-2032) Table 118. China Biomedical CRO Revenue by Type (2021-2026) & (US$ Million) Table 119. China Biomedical CRO Revenue by Type (2027-2032) & (US$ Million) Table 120. China Biomedical CRO Revenue by Application (2021-2026) & (US$ Million) Table 121. China Biomedical CRO Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia Biomedical CRO Revenue by Type (2021-2026) & (US$ Million) Table 123. Asia Biomedical CRO Revenue by Type (2027-2032) & (US$ Million) Table 124. Asia Biomedical CRO Revenue by Application (2021-2026) & (US$ Million) Table 125. Asia Biomedical CRO Revenue by Application (2027-2032) & (US$ Million) Table 126. Asia Biomedical CRO Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Asia Biomedical CRO Revenue by Region (US$ Million) & (2021-2026) Table 128. Asia Biomedical CRO Revenue by Region (US$ Million) & (2027-2032) Table 129. SAMEA Biomedical CRO Revenue by Type (2021-2026) & (US$ Million) Table 130. SAMEA Biomedical CRO Revenue by Type (2027-2032) & (US$ Million) Table 131. SAMEA Biomedical CRO Revenue by Application (2021-2026) & (US$ Million) Table 132. SAMEA Biomedical CRO Revenue by Application (2027-2032) & (US$ Million) Table 133. SAMEA Biomedical CRO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. SAMEA Biomedical CRO Revenue by Country (2021-2026) & (US$ Million) Table 135. SAMEA Biomedical CRO Revenue by Country (US$ Million) & (2027-2032) Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Biomedical CRO Image Figure 2. Global Biomedical CRO Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biomedical CRO Market Size Share 2021 VS 2025 VS 2032 Figure 4. Preclinical CRO Image Figure 5. Clinical CRO Image Figure 6. Global Biomedical CRO Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Biomedical CRO Market Size Share 2021 VS 2025 VS 2032 Figure 8. Biological Industry Image Figure 9. Medical Industry Image Figure 10. Global Biomedical CRO Market Size (US$ Million) & (2021-2032) Figure 11. Global Biomedical CRO Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Biomedical CRO Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Biomedical CRO Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Biomedical CRO Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Biomedical CRO Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Biomedical CRO Revenue Market Share by Type (2021-2032) Figure 18. Global Biomedical CRO Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Biomedical CRO Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Biomedical CRO Revenue Market Share by Application (2021-2032) Figure 21. North America Biomedical CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Biomedical CRO Revenue Share by Type (2021-2032) Figure 23. North America Biomedical CRO Revenue Share by Application (2021-2032) Figure 24. North America Biomedical CRO Revenue Share by Country (2021-2032) Figure 25. United States Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Biomedical CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Biomedical CRO Revenue Share by Type (2021-2032) Figure 30. Europe Biomedical CRO Revenue Share by Application (2021-2032) Figure 31. Europe Biomedical CRO Revenue Share by Country (2021-2032) Figure 32. Germany Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Biomedical CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Biomedical CRO Revenue Share by Type (2021-2032) Figure 42. China Biomedical CRO Revenue Share by Application (2021-2032) Figure 43. Asia Biomedical CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Biomedical CRO Revenue Share by Type (2021-2032) Figure 45. Asia Biomedical CRO Revenue Share by Application (2021-2032) Figure 46. Asia Biomedical CRO Revenue Share by Region (2021-2032) Figure 47. Japan Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Biomedical CRO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Biomedical CRO Revenue Share by Type (2021-2032) Figure 55. SAMEA Biomedical CRO Revenue Share by Application (2021-2032) Figure 56. SAMEA Biomedical CRO Revenue Share by Country (2021-2032) Figure 57. Brazil Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Biomedical CRO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Preclinical CRO
  • Clinical CRO
Applications
  • Biological Industry
  • Medical Industry
Companies covered
  • Charles River
  • Wuxi AppTec
  • Labcorp
  • Eurofins Scientific
  • PPD
  • ICON Plc
  • Pharmaron
  • Inotiv
  • ChemPartner
  • JOINN Lab
  • EVOTEC
  • Medicilon
  • Crown Bioscience
  • Champion Oncology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biomedical CRO Market by Type
  3. 1.2.1 Global Biomedical CRO Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Preclinical CRO
  5. 1.2.3 Clinical CRO
  6. 1.3 Biomedical CRO Market by Application
  7. 1.3.1 Global Biomedical CRO Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Biological Industry
  9. 1.3.3 Medical Industry
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Biomedical CRO Market Dynamics
  1. 2.1 Biomedical CRO Industry Trends
  2. 2.2 Biomedical CRO Industry Drivers
  3. 2.3 Biomedical CRO Industry Opportunities and Challenges
  4. 2.4 Biomedical CRO Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biomedical CRO Market Perspective (2021-2032)
  2. 3.2 Global Biomedical CRO Growth Trends by Region
  3. 3.2.1 Global Biomedical CRO Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biomedical CRO Market Size by Region (2021-2026)
  5. 3.2.3 Global Biomedical CRO Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biomedical CRO Revenue by Players
  2. 4.1.1 Global Biomedical CRO Revenue by Players (2021-2026)
  3. 4.1.2 Global Biomedical CRO Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biomedical CRO Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biomedical CRO Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biomedical CRO Key Players Headquarters & Area Served
  7. 4.4 Global Biomedical CRO Players, Product Type & Application
  8. 4.5 Global Biomedical CRO Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biomedical CRO Market CR5 and HHI
  11. 4.6.3 2025 Biomedical CRO Tier 1, Tier 2, and Tier 3
5 Biomedical CRO Market Size by Type
  1. 5.1 Global Biomedical CRO Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biomedical CRO Revenue by Type (2021-2032)
  3. 5.3 Global Biomedical CRO Revenue Market Share by Type (2021-2032)
6 Biomedical CRO Market Size by Application
  1. 6.1 Global Biomedical CRO Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biomedical CRO Revenue by Application (2021-2032)
  3. 6.3 Global Biomedical CRO Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Charles River
  2. 7.1.1 Charles River Company Information
  3. 7.1.2 Charles River Business Overview
  4. 7.1.3 Charles River Biomedical CRO Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Charles River Biomedical CRO Product Portfolio
  6. 7.1.5 Charles River Recent Developments
  7. 7.2 Wuxi AppTec
  8. 7.2.1 Wuxi AppTec Company Information
  9. 7.2.2 Wuxi AppTec Business Overview
  10. 7.2.3 Wuxi AppTec Biomedical CRO Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Wuxi AppTec Biomedical CRO Product Portfolio
  12. 7.2.5 Wuxi AppTec Recent Developments
  13. 7.3 Labcorp
  14. 7.3.1 Labcorp Company Information
  15. 7.3.2 Labcorp Business Overview
  16. 7.3.3 Labcorp Biomedical CRO Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Labcorp Biomedical CRO Product Portfolio
  18. 7.3.5 Labcorp Recent Developments
  19. 7.4 Eurofins Scientific
  20. 7.4.1 Eurofins Scientific Company Information
  21. 7.4.2 Eurofins Scientific Business Overview
  22. 7.4.3 Eurofins Scientific Biomedical CRO Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Eurofins Scientific Biomedical CRO Product Portfolio
  24. 7.4.5 Eurofins Scientific Recent Developments
  25. 7.5 PPD
  26. 7.5.1 PPD Company Information
  27. 7.5.2 PPD Business Overview
  28. 7.5.3 PPD Biomedical CRO Revenue and Gross Margin (2021-2026)
  29. 7.5.4 PPD Biomedical CRO Product Portfolio
  30. 7.5.5 PPD Recent Developments
  31. 7.6 ICON Plc
  32. 7.6.1 ICON Plc Company Information
  33. 7.6.2 ICON Plc Business Overview
  34. 7.6.3 ICON Plc Biomedical CRO Revenue and Gross Margin (2021-2026)
  35. 7.6.4 ICON Plc Biomedical CRO Product Portfolio
  36. 7.6.5 ICON Plc Recent Developments
  37. 7.7 Pharmaron
  38. 7.7.1 Pharmaron Company Information
  39. 7.7.2 Pharmaron Business Overview
  40. 7.7.3 Pharmaron Biomedical CRO Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pharmaron Biomedical CRO Product Portfolio
  42. 7.7.5 Pharmaron Recent Developments
  43. 7.8 Inotiv
  44. 7.8.1 Inotiv Company Information
  45. 7.8.2 Inotiv Business Overview
  46. 7.8.3 Inotiv Biomedical CRO Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Inotiv Biomedical CRO Product Portfolio
  48. 7.8.5 Inotiv Recent Developments
  49. 7.9 ChemPartner
  50. 7.9.1 ChemPartner Company Information
  51. 7.9.2 ChemPartner Business Overview
  52. 7.9.3 ChemPartner Biomedical CRO Revenue and Gross Margin (2021-2026)
  53. 7.9.4 ChemPartner Biomedical CRO Product Portfolio
  54. 7.9.5 ChemPartner Recent Developments
  55. 7.10 JOINN Lab
  56. 7.10.1 JOINN Lab Company Information
  57. 7.10.2 JOINN Lab Business Overview
  58. 7.10.3 JOINN Lab Biomedical CRO Revenue and Gross Margin (2021-2026)
  59. 7.10.4 JOINN Lab Biomedical CRO Product Portfolio
  60. 7.10.5 JOINN Lab Recent Developments
  61. 7.11 EVOTEC
  62. 7.11.1 EVOTEC Company Information
  63. 7.11.2 EVOTEC Business Overview
  64. 7.11.3 EVOTEC Biomedical CRO Revenue and Gross Margin (2021-2026)
  65. 7.11.4 EVOTEC Biomedical CRO Product Portfolio
  66. 7.11.5 EVOTEC Recent Developments
  67. 7.12 Medicilon
  68. 7.12.1 Medicilon Company Information
  69. 7.12.2 Medicilon Business Overview
  70. 7.12.3 Medicilon Biomedical CRO Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Medicilon Biomedical CRO Product Portfolio
  72. 7.12.5 Medicilon Recent Developments
  73. 7.13 Crown Bioscience
  74. 7.13.1 Crown Bioscience Company Information
  75. 7.13.2 Crown Bioscience Business Overview
  76. 7.13.3 Crown Bioscience Biomedical CRO Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Crown Bioscience Biomedical CRO Product Portfolio
  78. 7.13.5 Crown Bioscience Recent Developments
  79. 7.14 Champion Oncology
  80. 7.14.1 Champion Oncology Company Information
  81. 7.14.2 Champion Oncology Business Overview
  82. 7.14.3 Champion Oncology Biomedical CRO Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Champion Oncology Biomedical CRO Product Portfolio
  84. 7.14.5 Champion Oncology Recent Developments
8 North America
  1. 8.1 North America Biomedical CRO Revenue (2021-2032)
  2. 8.2 North America Biomedical CRO Revenue by Type (2021-2032)
  3. 8.2.1 North America Biomedical CRO Revenue by Type (2021-2026)
  4. 8.2.2 North America Biomedical CRO Revenue by Type (2027-2032)
  5. 8.3 North America Biomedical CRO Revenue Share by Type (2021-2032)
  6. 8.4 North America Biomedical CRO Revenue by Application (2021-2032)
  7. 8.4.1 North America Biomedical CRO Revenue by Application (2021-2026)
  8. 8.4.2 North America Biomedical CRO Revenue by Application (2027-2032)
  9. 8.5 North America Biomedical CRO Revenue Share by Application (2021-2032)
  10. 8.6 North America Biomedical CRO Revenue by Country
  11. 8.6.1 North America Biomedical CRO Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biomedical CRO Revenue by Country (2021-2026)
  13. 8.6.3 North America Biomedical CRO Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biomedical CRO Revenue (2021-2032)
  2. 9.2 Europe Biomedical CRO Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biomedical CRO Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biomedical CRO Revenue by Type (2027-2032)
  5. 9.3 Europe Biomedical CRO Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biomedical CRO Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biomedical CRO Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biomedical CRO Revenue by Application (2027-2032)
  9. 9.5 Europe Biomedical CRO Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biomedical CRO Revenue by Country
  11. 9.6.1 Europe Biomedical CRO Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biomedical CRO Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biomedical CRO Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biomedical CRO Revenue (2021-2032)
  2. 10.2 China Biomedical CRO Revenue by Type (2021-2032)
  3. 10.2.1 China Biomedical CRO Revenue by Type (2021-2026)
  4. 10.2.2 China Biomedical CRO Revenue by Type (2027-2032)
  5. 10.3 China Biomedical CRO Revenue Share by Type (2021-2032)
  6. 10.4 China Biomedical CRO Revenue by Application (2021-2032)
  7. 10.4.1 China Biomedical CRO Revenue by Application (2021-2026)
  8. 10.4.2 China Biomedical CRO Revenue by Application (2027-2032)
  9. 10.5 China Biomedical CRO Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biomedical CRO Revenue (2021-2032)
  2. 11.2 Asia Biomedical CRO Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biomedical CRO Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biomedical CRO Revenue by Type (2027-2032)
  5. 11.3 Asia Biomedical CRO Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biomedical CRO Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biomedical CRO Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biomedical CRO Revenue by Application (2027-2032)
  9. 11.5 Asia Biomedical CRO Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biomedical CRO Revenue by Country
  11. 11.6.1 Asia Biomedical CRO Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biomedical CRO Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biomedical CRO Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biomedical CRO Revenue (2021-2032)
  2. 12.2 SAMEA Biomedical CRO Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biomedical CRO Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biomedical CRO Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biomedical CRO Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biomedical CRO Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biomedical CRO Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biomedical CRO Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biomedical CRO Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biomedical CRO Revenue by Country
  11. 12.6.1 SAMEA Biomedical CRO Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biomedical CRO Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biomedical CRO Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst